EW vs LAB · P/E 47, rev $1.39B vs rev $174.4M
Edwards Lifesciences Corp (EW) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. LAB currently screens at market cap $317.1M.
Not investment advice. Open the EW and LAB stock pages for the full models.
Not investment advice.